About the Product

Description


Zidovile 300 Tablet contains Zidovudine 300mg, a nucleoside reverse transcriptase inhibitor (NRTI) used in combination antiretroviral therapy for HIV infection. It helps reduce viral replication and maintain immune system function.

Zidovudine works by blocking the reverse transcriptase enzyme, preventing the HIV virus from multiplying. This action helps decrease viral load and slow the progression of HIV when taken as part of a prescribed treatment plan.

This Tablet is commonly used in adults requiring higher doses for effective viral suppression, providing a convenient once-daily or twice-daily dosing option under medical supervision.

Zidovile 300 Tablet is valued for its proven clinical efficacy, consistent therapeutic results, and established role in HIV management programs. It is a trusted choice in antiretroviral therapy, supporting long-term viral suppression and improved patient outcomes.


Common side effects may include headache, nausea, vomiting, fatigue, anemia, or loss of appetite. Long-term or high-dose use may lead to muscle weakness, neutropenia, or liver enzyme abnormalities. Patients should report any unusual symptoms to their healthcare provider promptly.

Zidovile 300 Tablet is indicated for the treatment of HIV infection in adults and adolescents. It is also used in preventing mother-to-child transmission of HIV during pregnancy, labor, and breastfeeding under medical supervision. This medicine is always used as part of a multi-drug therapy regimen.

Zidovile 300 Tablet must be taken exactly as prescribed by a healthcare professional. Do not stop or change the dose without consulting your doctor. Regular monitoring of blood counts and liver function is recommended during therapy. Avoid combining with other medications without medical advice to prevent interactions.

Store Zidovile 300 Tablet in a cool, dry place, protected from light and moisture. Keep out of reach of children and do not use beyond the expiry date printed on the packaging.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions

What are the business opportunities for Zidovile 300 Tablet (Zidovudine 300mg) in the PCD pharma franchise market?

Zidovile 300 Tablet has strong demand in the antiretroviral (HIV/AIDS) specialty-care segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on infectious diseases and hospital supply portfolios.

Why should medical distributors include Zidovile 300 Tablet in their product range?

Medical distributors and agencies can benefit from consistent demand for management of HIV-1 infection as part of combination antiretroviral therapy (ART). Zidovudine 300mg is an NRTI (nucleoside reverse transcriptase inhibitor) that helps reduce HIV viral replication Commonly used in long-term combination therapy protocols for better disease control This strengthens a reliable infectious disease and specialty-care portfolio.

Does Cafoli LifeCare Pvt Ltd offer PCD pharma franchise opportunities for Zidovile 300 Capsule?

Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Zidovile 300 Capsule with promotional support, monopoly rights, quality packaging, and competitive pricing for distributors and wholesalers.

What benefits do wholesalers get by partnering for Zidovile 300 Tablet?

Wholesalers and medical agencies benefit from strong hospital and government supply demand, long-term chronic therapy usage, institutional procurement opportunities, reliable supply chain support, and stable margins in antiretroviral medicines.

How can I become a distributor or franchise partner for Zidovile 300 Tablet?

Interested distributors, stockists, and wholesalers can contact Cafoli LifeCare Pvt Ltd to discuss pricing, monopoly territory rights, and distribution opportunities.